544 related articles for article (PubMed ID: 1386348)
1. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
4. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
5. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.
Gorter A; Krüse KM; Schrier PI; Fleuren GJ; van de Griend RJ
Clin Exp Immunol; 1992 Jan; 87(1):111-6. PubMed ID: 1531120
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
[TBL] [Abstract][Full Text] [Related]
8. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
9. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
10. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
LeMay LG; Kan-Mitchell J; Goedegebuure P; Harel W; Mitchell MS
Cancer Immunol Immunother; 1993 Aug; 37(3):187-94. PubMed ID: 8101473
[TBL] [Abstract][Full Text] [Related]
11. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
12. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation.
Zhao X; Wei YQ; Kariya Y; Teshigawara K; Uchida A
Immunol Invest; 1995 May; 24(4):607-18. PubMed ID: 7622197
[TBL] [Abstract][Full Text] [Related]
14. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.
Wölfel T; Herr W; Coulie P; Schmitt U; Meyer zum Büschenfelde KH; Knuth A
Int J Cancer; 1993 Jun; 54(4):636-44. PubMed ID: 8514455
[TBL] [Abstract][Full Text] [Related]
15. HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.
Wang P; Végh Zs; Vánky F; Klein E
Int J Cancer; 1992 Oct; 52(4):517-22. PubMed ID: 1399129
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.
Nisticò P; De Berardinis P; Morrone S; Alonzi T; Buono C; Venturo I; Natali PG
J Clin Invest; 1994 Oct; 94(4):1426-31. PubMed ID: 7929817
[TBL] [Abstract][Full Text] [Related]
17. The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.
Chikamatsu K; Eura M; Matsuoka H; Murakami H; Fukiage T; Ishikawa T
Cancer Immunol Immunother; 1994 Jun; 38(6):358-64. PubMed ID: 8205556
[TBL] [Abstract][Full Text] [Related]
18. T-cell clones that react against autologous human tumors.
Mukherji B; Chakraborty NG; Sivanandham M
Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
[TBL] [Abstract][Full Text] [Related]
20. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
